BRAF is a cytoplasmic serine-threonine protein kinase and commonly mutated in thyroid cancer and mutations in BRAF result in constitutive activation, thus promoting proliferation, tumorigenicity and dedifferentiation [[15], [16], [17]]. The gene discussed is BRAF; the disease is thyroid gland carcinoma.